Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.65 USD
Change Today +0.09 / 1.05%
Volume 440.2K
INFI On Other Exchanges
Symbol
Exchange
Frankfurt
As of 4:30 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - INFINITY PHARMACEUTICALS INC (INFI)

Infinity Pharmaceuticals, Inc. to Report Q2, 2012 on Aug 07, 2012
CapIQ 08/07/2012 4:00 AM ET
Infinity Pharmaceuticals, Inc. to Report Q4, 2010 on Feb 09, 2011
CapIQ 08/07/2012 4:00 AM ET
Infinity Pharmaceuticals, Inc. to Report Q3, 2010 on Nov 09, 2010
CapIQ 08/07/2012 4:00 AM ET

2013 revenues at Infinity Pharmaceuticals, Inc. totaled $0.0 USD, while annual losses equaled $2.64 per share.

Quarterly Earnings & Estimates - INFINITY PHARMACEUTICALS INC (INFI)

Actuals vs. Estimates for INFINITY PHARMACEUTICALS INC INFI

Infinity Pharmaceuticals, Inc.'s Quarterly Earnings

Infinity Pharmaceuticals, Inc. reported 1st quarter 2014 losses of $0.87 per share on 05/8/2014.

Annual Earnings & Estimates - INFINITY PHARMACEUTICALS INC (INFI)

Actuals vs. Estimates for INFINITY PHARMACEUTICALS INC INFI

Infinity Pharmaceuticals, Inc.'s Annual Earnings

Infinity Pharmaceuticals, Inc. reported annual 2013 losses of $2.64 per share on 02/27/2014.

Quarterly Revenues - INFINITY PHARMACEUTICALS INC (INFI)

Actuals vs. Estimates for INFINITY PHARMACEUTICALS INC INFI

Infinity Pharmaceuticals, Inc.'s Quarterly Revenues

Infinity Pharmaceuticals, Inc. did not report revenues for the 1st quarter 2014. However, during the 1st quarter of the prior year the company reported revenues of $0.0 USD.

Annual Revenues - INFINITY PHARMACEUTICALS INC (INFI)

Actuals vs. Estimates for INFINITY PHARMACEUTICALS INC INFI

Infinity Pharmaceuticals, Inc.'s Annual Revenues

Infinity Pharmaceuticals, Inc. did not report revenues for the full year 2013. However, during the prior year the company reported revenues of $47.1M USD.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INFI:US $8.65 USD +0.09

INFI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CTI BioPharma Corp $1.52 USD -0.03
Curis Inc $2.52 USD -0.04
Cytokinetics Inc $7.20 USD +0.16
Evotec AG €3.75 EUR -0.032
GlaxoSmithKline SAE £10.00 EGP 0.00
View Industry Companies
 

Industry Analysis

INFI

Industry Average

Valuation INFI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book 5.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INFINITY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.